摘要
观察血府逐瘀丸对动脉粥样硬化血瘀征象和危险因素的影响。方法：将５７例患者随机分为血府逐瘀丸组（３０例）和阿斯匹林组（２７例），分别给予血府逐瘀丸口服，每次 ６ｇ，每日 ３次。小剂量阿斯匹林每次 ４０ｍｇ，每日 １次，治疗 １个月。结果：血府逐瘀丸能够改善动脉粥样硬化患者的血瘀证候（Ｐ＜０．０１），降低体内动脉粥样硬化危险因素──高血胆固醇（Ｐ＜０．０５）、氧化低密度脂蛋白（Ｐ＜０．０５）和血浆内。颗粒膜蛋白水平（Ｐ＜０．０１）。结论：血府逐瘀丸对延缓动脉粥样硬化有一定积极作用。
To observe the effect of Xuefuzhuyu Pill (XFZYP) on blood stasis syndrome and risk factor of atherosclerosis. Methods: Fifty-seven patients of atherosclerosis were randomly divided into XFZYP group (30 cases) and aspirin group (27 cases) treated with XFZYP (6g, three times daily) and aspirin (40mg per day) oral taken respectively for one month. Results: XFZYP could improve blood stasis syndrome of patients (P<0.01) and reduced the level of risk factor of atherosclerosis, including high blood cholesterol (P<0.01), oxidation of low density lipoprotein (P<0.05) and plasma granule membrane protein Q (P<0.01). Conclusion: XFZYP is beneficial to retard the progress of atherosclerosis.
出处
《中国中西医结合杂志》
CAS
CSCD
北大核心
1998年第2期71-73,共3页
Chinese Journal of Integrated Traditional and Western Medicine
关键词
动脉粥样硬化
血瘀证
血府逐瘀丸
危险因素
atherosclerosis, blood stasis syndrome, Xuefu Zhugu Pill, oxidation of low density lipoprotein, lipoprotein a, α-plasma granule membrane protein 140
